コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 case scenarios that apply the principles of evidence-based medicine.
2 clinical trials are a fundamental aspect of evidence-based medicine.
3 nship and contribute to the overall goals of evidence-based medicine.
4 through 4 situations that use principles of evidence-based medicine.
5 Systematic reviews have a central role in evidence-based medicine.
6 ed using criteria from the Oxford Centre for Evidence-Based Medicine.
7 vision of the future of clinical trials and evidence-based medicine.
8 rane Risk of Bias tool and Oxford Centre for Evidence-Based Medicine.
9 a fundamental tool for the dissemination of evidence-based medicine.
10 re graded according to the Oxford Centre for Evidence-Based Medicine.
11 ecommendation based on the Oxford Center for Evidence-Based Medicine.
12 ation of this form of bias as it pertains to evidence-based medicine.
13 re graded according to the Oxford Centre for Evidence-Based Medicine.
14 g microbiologic failure, relapse, or ADR, in evidence-based medicine.
15 are the gold standard method for developing evidence-based medicine.
16 ficulties in reconciling its principles with evidence-based medicine.
17 practice is among the greatest challenges to evidence-based medicine.
18 in coronary artery disease relies heavily on evidence-based medicine.
19 clinical trials (RCTs) are a cornerstone of evidence-based medicine.
21 s information was obtained from a guidebook "Evidence-Based Medicine 2018 SCL " which was published b
24 ncreasing efforts to promote the practice of evidence-based medicine among surgeons, although it is u
26 Systematic reviews are a major component of evidence-based medicine and can be adapted to CER by bro
27 e machine-physician ecosystem that relies on evidence-based medicine and can potentially enhance PD m
29 with the principles and methods utilized in evidence-based medicine and health care, with emphasis o
30 d controlled trials (RCTs) are essential for evidence-based medicine and increasingly rely on front-l
31 , and discouraging clinicians from following evidence-based medicine and recommending proven treatmen
32 offer an unparalleled opportunity to advance evidence-based medicine and support decision-making.
34 uaint practitioners with the fundamentals of evidence-based medicine and to provide examples of how t
36 compliance with evidence-based guidelines or evidence-based medicine, and in short-term length of sta
37 ist of voluntary peer pressure to conform to evidence-based medicine, and it does not require a finan
38 ched PubMed, Embase, Ovid, Cochrane Library, Evidence-Based Medicine, and the American College of Phy
39 e not changed (until recently), insufficient evidence-based medicine, and the lack of motivation by p
40 is lens, this example will illustrate how an evidence-based medicine approach can be used to individu
47 Randomized clinical trials are central to evidenced-based medicine, but low patient participation
48 ectiveness analysis can further the goals of evidence-based medicine by facilitating the synthesis of
49 This series aims to advance the practice of evidence-based medicine by helping in redesign of medica
50 RCT are considered to be the cornerstone of evidence-based medicine by representing the highest leve
55 s (QUIPS), evidence quality using Centre for Evidence-Based Medicine (CEBM), and certainty of evidenc
57 nformation, be it originating from research, evidence-based medicine, clinical findings, patient expe
59 ng, US, Head/Neck, Thorax, Brain/Brain Stem, Evidence-based Medicine, Computer Applications-General (
62 reveal that physicians feel that practicing evidence-based medicine could be difficult in a busy cli
64 cations (level 1B based on Oxford Centre for Evidence-Based Medicine criteria) and atomoxetine than f
68 divergence between patient perspectives and evidence-based medicine despite probably sharing the sam
69 ment of effective health-care strategies and evidence-based medicine directly linked to innovative ca
70 understanding and use of published evidence, evidence-based medicine (EBM) began as a movement in the
72 the emergence of systematic reviews and the evidence-based medicine (EBM) movement have also contrib
74 bed culturally in the workplace, teaching of evidence-based medicine (EBM) should be clinically integ
75 comparative effectiveness research (CER) and evidence-based medicine (EBM); (2) to describe the impli
78 efficacy of phage therapy, as is required by evidence-based medicine, existing data suggest that phag
79 nterrelated approaches to usher in an era of evidence-based medicine for optimal management of immuno
80 and should be screened annually according to evidence-based medicine for the early detection of secon
87 how often do we do what we should (i.e., use evidence-based medicine), how do we know we learned from
88 an group intelligence can be used to support evidence based medicine in a way that is automated and c
89 ity of a therapy, and discuss challenges for evidence-based medicine in guiding care precisely target
90 w the benefits of and barriers to the use of evidence-based medicine in pediatrics in the twenty-firs
94 he to complexities and nuances of practicing evidence-based medicine in the setting of heavy regulato
96 ramme in the context of the UK landscape for evidence-based medicine, including in relation to the Na
111 ause clinical research is the foundation for evidence-based medicine, it is imperative that this disp
112 Evidence was graded using Oxford Centre for Evidence-Based Medicine levels of evidence for treatment
113 s were evaluated using the Oxford Centre for Evidence-Based Medicine Levels of Evidence tool and Risk
114 rized as category LR-M.Keywords: Abdomen/GI, Evidence Based Medicine, Liver, Neoplasms-Primary, Ultra
115 ional subject areas (eg, cultural diversity, evidence-based medicine, medical ethics, medical informa
116 link between relationship-centered care and evidence-based medicine, mindfulness should be considere
117 lly ill patients every day without clear-cut evidence-based medicine (more subjective than objective
118 les applying two NE scales (Oxford Center of Evidence Based Medicine (OCEBM) y National Health and Me
119 and machine learning have begun to transform evidence-based medicine, offering a tantalizing glimpse
120 housands of neurons; fifth, the influence of evidence-based medicine on neurorehabilitation; and sixt
122 consensus statements (CSs) are used to apply evidence-based medicine or expert recommendations to cli
123 archers and clinicians who are interested in evidence-based medicine or involved in guideline develop
125 s produce more recommendations violating the evidence based medicine principles than evidence based g
126 medicine, the appropriate application of key evidence-based medicine principles in clinical decision
127 ogists should seek to become involved in the evidence-based medicine process by supporting the accrua
131 a modified version of the Oxford Centre for Evidence-Based Medicine quality rating scheme for indivi
132 These studies will assist in the practice of evidence-based medicine regarding pediatric hypertension
137 conducted using CINAHL, MEDLINE, PsychoINFO, Evidence Based Medicine Reviews, Cochrane Review databas
138 EDLINE, CINAHL, PsycInfo, Global Health, and Evidence-Based Medicine Reviews Cochrane Database of Sys
139 was conducted using MEDLINE, EMBASE, and the evidence-based medicine reviews from inception through F
140 1955, and March 31, 2015, in PubMed, Embase, Evidence-Based Medicine Reviews, Allied and Complementar
141 These databases included MEDLINE, Embase, Evidence-Based Medicine Reviews, CINAHL, Cochrane Databa
142 tion Taxonomy criteria and Oxford Centre for Evidence-based Medicine's Levels of Evidence and Grades
143 a modified version of the Oxford Centre for Evidence-Based Medicine scheme for rating individual stu
146 ardization of data across platforms, promote evidence-based medicine, support shared decision making,
147 ropriate treatment of gout, identify gaps in evidence-based medicine that perpetuate those myths, and
148 art of the logical evolution of contemporary evidence-based medicine that seeks to reduce errors and
149 Although physicians have generally welcomed evidence-based medicine, the benefits and limitations ar
152 als are generally considered the pinnacle of evidence-based medicine, they are not infrequently poorl
153 ity to build on its pioneering leadership in evidence-based medicine through major initiatives now un
154 criteria designated by the Oxford Centre for Evidence-Based Medicine to determine the level of eviden
156 nt, and can serve as a template for applying evidence-based medicine to inform treatment decisions fo
158 as an example, we describe the importance of evidence-based medicine to the development of disease ma
159 cular emphasis on applying the principles of evidence-based medicine to the evaluation of surgical th
162 icle reviews the current recommendations and evidence-based medicine, where available, for the medica
163 e AHA to support and further the delivery of evidence-based medicine, which includes the following: (
165 If this mismatch is not addressed, then evidence-based medicine will not be representative of co
166 y recent phenomenon, promoted as a tenet of "evidence-based medicine," with randomized controlled tri
167 Publication bias compromises the validity of evidence-based medicine, yet a growing body of research
168 e review holds great potential for enhancing evidence-based medicine, yet has been limited by insuffi